Cargando…
Cerebral Venous Sinus Thrombosis After BNT162b2 mRNA COVID-19 Vaccination
W present a rare case of cerebral venous sinus thrombosis after the BNT162b2 mRNA COVID-19 vaccine. A 61-year-old Japanese man developed a headache 10 days after the first dose of the vaccine. Magnetic resonance venography and contrast-enhanced brain MRI showed thrombosis in the superior sagittal si...
Autores principales: | Yamaguchi, Yoshitaka, Kimihira, Luna, Nagasawa, Hikaru, Seo, Kyoichi, Wada, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590453/ https://www.ncbi.nlm.nih.gov/pubmed/34796065 http://dx.doi.org/10.7759/cureus.18775 |
Ejemplares similares
-
Cognitive impairment due to widespread enlarged perivascular spaces
por: Yamaguchi, Yoshitaka, et al.
Publicado: (2021) -
Role of Decompressive Craniectomy in the Management of Cerebral Venous Sinus Thrombosis
por: Avanali, Raghunath, et al.
Publicado: (2019) -
Cerebral Venous Sinus Thrombosis in COVID-19: An Unusual Presentation
por: Kaur, Ikwinder, et al.
Publicado: (2021) -
Cerebral Venous Sinus Thrombosis After Pfizer-BioNTech COVID-19 (BNT162b2) Vaccination
por: Cheng, Newman
Publicado: (2021) -
Thyroid Diseases Are an Underestimated Risk Factor for Cerebral Venous Sinus Thrombosis
por: Hieber, Maren, et al.
Publicado: (2020)